Innovative approaches in large-scale research infrastructures

Join us in Copenhagen for the Biobank symposium 17th - 18th November 2021

Description

The covid-19 pandemic has made the strengths of biobanks and research partnership even more prominent. The availability of stored positive samples combined with other biological samples and clinical data from the same individuals will enable unprecedented host-pathogen genetics studies. The large number of samples collected from covid-19 serology studies can potentially be used in conjunction with epidemiological data and general health data to elucidate factors relevant for studying covid-19 immunity.

These factors combined makes biobanks and large datasets attractive to both academia and industry. In the recent years several drugs have been developed based on genetic discoveries from biobank material. This availability of large-scale datasets from biological material is very attractive for the pharmaceutical industry and has led to increased funding from industry partners for large scale genetic projects. All in all there is an increasing focus on public-private partnerships.

With this biobank symposium, we will bring together world leading biobanks and researchers and discuss how we can use innovative approaches and expanded cooperation with the pharmaceutical industry to improve health care.

Keynote speakers

  • Marina Pollan from Health Institute Carlos III in Madrid - "Learnings from the Spanish nationwide covid seroprevalens study"
  • Søren Brunak from Center for Protein Research at University of Copenhagen - "Advanced pathway analysis to unravel new disease understanding"
  • Jens Habermann from BBMRI-ERIC - "European networks fostering cross-country collaborations"

The two day symposium will be held at Statens Serum Institut in Copenhagen with a mixture of classical talks, poster sessions, networking and social activities.

Programme

The symposium programme is available here:

Innovative approaches in large-scale research infrastructures

List of speakers

  • Marina Pollan, Health Institute Carlos III
  • Peter Garred, Department of Clinical Immunology, Rigshospitalet
  • Niels Tommerup, Department of Cellular and Molecular Medicine, University of Copenhagen
  • Tune Pers, Center fra Basic Metabolic Research, University of Copenhagen
  • Søren Brunak, Center for Protein Research, University of Copenhagen
  • Marco Hautalahti, Finnish Biobanks Cooperative (FINBB)
  • Batlomiej Wilkowski, Danish National Biobank
  • Frederik Knud Nielsen, Novartis
  • Marianne Pilgaard, Trial Nation
  • Lila Kallio, Auria Biobank
  • Jens Habermann, BBMRI-ERIC
  • Sandra Liede, Healthtech Finland
  • Eva Ortega-Paíno, Spanish National Cancer Research Centre
  • Jakob Bjerg Larsen, The Danish Association of the Pharmaceutical Industry (LIF)

Short talks, poster presentation and travel grants

The programme has two slots for young researchers to present their results. The presenters will be selected among the submitted abstracts.

All submitted abstracts will be presented at the poster session to ensure networking and to enable young scientists to present their results. There will be poster prizes for the best, second best and third best posters.

Further, DKK 5,000 travel grants are available for the best abstracts submitted by foreign researchers.

Practical information

  • Registration and participation is free of charge.
  • Lunch, coffee, tea and refreshments are included.
  • In case of cancellation, please contact sokm@ssi.dk.
  • The symposium will be held at Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S. Easily accessible with public transportation.
  • Organizers: Danish National Biobank, Spanish National Cancer Research Centre and University of Helsinki.
  • Kindly funded by Novo Nordisk Foundation.

Registration